Literature DB >> 29592530

To teach an old dog new tricks: The limits of CHA2DS2-VASc in patients with atrial fibrillation and cancer.

Xiaoxi Yao1,2, Peter A Noseworthy1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29592530     DOI： 10.1177/2047487318766942

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  3 in total

Review 1.  Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer-a network meta-analysis.

Authors:  Pingping Yang; Dan Zhu; Xiuxiu Xu; Wen Shen; Chenxi Wang; Yu Jiang; Gaosi Xu; Qinghua Wu
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

2.  Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Yuqing Deng; Yifan Tong; Yuanyuan Deng; Le Zou; Shunhui Li; Hui Chen
Journal:  J Am Heart Assoc       Date:  2019-07-16       Impact factor: 5.501

3.  Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016.

Authors:  Shirin Ardeshirrouhanifard; Huijun An; Ravi K Goyal; Mukaila A Raji; Jodi B Segal; G Caleb Alexander; Hemalkumar B Mehta
Journal:  Pharmacotherapy       Date:  2022-04-14       Impact factor: 6.251
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.